However, subsequent studies by Parker's group and this study with a mutant ERα rule out coactivator competition as being the primary mechanism of transrepression, at least in breast cancer cells (Sheppard et al, 1999; Harnish et al, 2000; Valentine et al, 2000). The gene discussed is ESR1; the disease is breast carcinoma.